 | • レポートコード：GIR-105X02592 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、86ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ビスフォスフォネート治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ビスフォスフォネート治療薬の種類別市場規模（アレンドロネート、リセドロネート、ゾレドロン酸、その他）、用途別市場規模（閉経後骨粗鬆症、骨粗鬆症男性、パジェット病、癌治療による骨量減少、小児骨粗鬆症不完全症）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ビスフォスフォネート治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Merck、Teva、Mylan、Apotex Corp、Cobalt Pharmaceuticals、Genentech、Novartis Pharmaceuticals、Sanofi-Aventis ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：アレンドロネート、リセドロネート、ゾレドロン酸、その他 ・用途別分析2016年-2026年：閉経後骨粗鬆症、骨粗鬆症男性、パジェット病、癌治療による骨量減少、小児骨粗鬆症不完全症 ・ビスフォスフォネート治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ビスフォスフォネート治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ビスフォスフォネート治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ビスフォスフォネート治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ビスフォスフォネート治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Bisphosphonate Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Bisphosphonate Drug size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Bisphosphonate Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Bisphosphonate Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Alendronate
Risedronate
Zoledronic Acid
Other Bisphosphonate Drug
Market segment by Application can be divided into
Postmenopausal Osteoporosis
Men with Osteoporosis
Paget’s Disease
Bone Loss Caused by Cancer Treatment
Osteoporosis Imperfecta in Children
The key market players for global Bisphosphonate Drug market are listed below:
Merck
Teva
Mylan
Apotex Corp
Cobalt Pharmaceuticals
Genentech
Novartis Pharmaceuticals
Sanofi-Aventis
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Bisphosphonate Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Bisphosphonate Drug, with price, sales, revenue and global market share of Bisphosphonate Drug from 2019 to 2021.
Chapter 3, the Bisphosphonate Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bisphosphonate Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Bisphosphonate Drug market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Bisphosphonate Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Bisphosphonate Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Bisphosphonate Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Alendronate
1.2.3 Risedronate
1.2.4 Zoledronic Acid
1.2.5 Other Bisphosphonate Drug
1.3 Market Analysis by Application
1.3.1 Overview: Global Bisphosphonate Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Postmenopausal Osteoporosis
1.3.3 Men with Osteoporosis
1.3.4 Paget’s Disease
1.3.5 Bone Loss Caused by Cancer Treatment
1.3.6 Osteoporosis Imperfecta in Children
1.4 Global Bisphosphonate Drug Market Size & Forecast
1.4.1 Global Bisphosphonate Drug Sales in Value (2016-2026))
1.4.2 Global Bisphosphonate Drug Sales in Volume (2016-2026)
1.4.3 Global Bisphosphonate Drug Price by Type (2016-2026) & (USD/Unit)
1.5 Global Bisphosphonate Drug Production Capacity Analysis
1.5.1 Global Bisphosphonate Drug Total Production Capacity (2016-2026)
1.5.2 Global Bisphosphonate Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Bisphosphonate Drug Market Drivers
1.6.2 Bisphosphonate Drug Market Restraints
1.6.3 Bisphosphonate Drug Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Bisphosphonate Drug Product and Services
2.1.4 Merck Bisphosphonate Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Teva
2.2.1 Teva Details
2.2.2 Teva Major Business
2.2.3 Teva Bisphosphonate Drug Product and Services
2.2.4 Teva Bisphosphonate Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business
2.3.3 Mylan Bisphosphonate Drug Product and Services
2.3.4 Mylan Bisphosphonate Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Apotex Corp
2.4.1 Apotex Corp Details
2.4.2 Apotex Corp Major Business
2.4.3 Apotex Corp Bisphosphonate Drug Product and Services
2.4.4 Apotex Corp Bisphosphonate Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Cobalt Pharmaceuticals
2.5.1 Cobalt Pharmaceuticals Details
2.5.2 Cobalt Pharmaceuticals Major Business
2.5.3 Cobalt Pharmaceuticals Bisphosphonate Drug Product and Services
2.5.4 Cobalt Pharmaceuticals Bisphosphonate Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Genentech
2.6.1 Genentech Details
2.6.2 Genentech Major Business
2.6.3 Genentech Bisphosphonate Drug Product and Services
2.6.4 Genentech Bisphosphonate Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Novartis Pharmaceuticals
2.7.1 Novartis Pharmaceuticals Details
2.7.2 Novartis Pharmaceuticals Major Business
2.7.3 Novartis Pharmaceuticals Bisphosphonate Drug Product and Services
2.7.4 Novartis Pharmaceuticals Bisphosphonate Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Sanofi-Aventis
2.8.1 Sanofi-Aventis Details
2.8.2 Sanofi-Aventis Major Business
2.8.3 Sanofi-Aventis Bisphosphonate Drug Product and Services
2.8.4 Sanofi-Aventis Bisphosphonate Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Bisphosphonate Drug Sales by Manufacturer
3.1 Global Bisphosphonate Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Bisphosphonate Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Bisphosphonate Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Bisphosphonate Drug Manufacturer Market Share
3.4.2 Top 6 Bisphosphonate Drug Manufacturer Market Share
3.5 Global Bisphosphonate Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Bisphosphonate Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Bisphosphonate Drug Market Size by Region
4.1.1 Global Bisphosphonate Drug Sales in Volume by Region (2016-2026)
4.1.2 Global Bisphosphonate Drug Revenue by Region (2016-2026)
4.2 North America Bisphosphonate Drug Revenue (2016-2026)
4.3 Europe Bisphosphonate Drug Revenue (2016-2026)
4.4 Asia-Pacific Bisphosphonate Drug Revenue (2016-2026)
4.5 South America Bisphosphonate Drug Revenue (2016-2026)
4.6 Middle East and Africa Bisphosphonate Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Bisphosphonate Drug Sales in Volume by Type (2016-2026)
5.2 Global Bisphosphonate Drug Revenue by Type (2016-2026)
5.3 Global Bisphosphonate Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Bisphosphonate Drug Sales in Volume by Application (2016-2026)
6.2 Global Bisphosphonate Drug Revenue by Application (2016-2026)
6.3 Global Bisphosphonate Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Bisphosphonate Drug Sales by Type (2016-2026)
7.2 North America Bisphosphonate Drug Sales by Application (2016-2026)
7.3 North America Bisphosphonate Drug Market Size by Country
7.3.1 North America Bisphosphonate Drug Sales in Volume by Country (2016-2026)
7.3.2 North America Bisphosphonate Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Bisphosphonate Drug Sales by Type (2016-2026)
8.2 Europe Bisphosphonate Drug Sales by Application (2016-2026)
8.3 Europe Bisphosphonate Drug Market Size by Country
8.3.1 Europe Bisphosphonate Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe Bisphosphonate Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Bisphosphonate Drug Sales by Type (2016-2026)
9.2 Asia-Pacific Bisphosphonate Drug Sales by Application (2016-2026)
9.3 Asia-Pacific Bisphosphonate Drug Market Size by Region
9.3.1 Asia-Pacific Bisphosphonate Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Bisphosphonate Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Bisphosphonate Drug Sales by Type (2016-2026)
10.2 South America Bisphosphonate Drug Sales by Application (2016-2026)
10.3 South America Bisphosphonate Drug Market Size by Country
10.3.1 South America Bisphosphonate Drug Sales in Volume by Country (2016-2026)
10.3.2 South America Bisphosphonate Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Bisphosphonate Drug Sales by Type (2016-2026)
11.2 Middle East & Africa Bisphosphonate Drug Sales by Application (2016-2026)
11.3 Middle East & Africa Bisphosphonate Drug Market Size by Country
11.3.1 Middle East & Africa Bisphosphonate Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Bisphosphonate Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Bisphosphonate Drug Typical Distributors
12.3 Bisphosphonate Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Bisphosphonate Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global Bisphosphonate Drug Revenue by Application, (USD Million), 2021-2026
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Bisphosphonate Drug Product and Services
Table 6. Merck Bisphosphonate Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Teva Basic Information, Manufacturing Base and Competitors
Table 8. Teva Major Business
Table 9. Teva Bisphosphonate Drug Product and Services
Table 10. Teva Bisphosphonate Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Mylan Basic Information, Manufacturing Base and Competitors
Table 12. Mylan Major Business
Table 13. Mylan Bisphosphonate Drug Product and Services
Table 14. Mylan Bisphosphonate Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Apotex Corp Basic Information, Manufacturing Base and Competitors
Table 16. Apotex Corp Major Business
Table 17. Apotex Corp Bisphosphonate Drug Product and Services
Table 18. Apotex Corp Bisphosphonate Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Cobalt Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Cobalt Pharmaceuticals Major Business
Table 21. Cobalt Pharmaceuticals Bisphosphonate Drug Product and Services
Table 22. Cobalt Pharmaceuticals Bisphosphonate Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Genentech Basic Information, Manufacturing Base and Competitors
Table 24. Genentech Major Business
Table 25. Genentech Bisphosphonate Drug Product and Services
Table 26. Genentech Bisphosphonate Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Novartis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 28. Novartis Pharmaceuticals Major Business
Table 29. Novartis Pharmaceuticals Bisphosphonate Drug Product and Services
Table 30. Novartis Pharmaceuticals Bisphosphonate Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Sanofi-Aventis Basic Information, Manufacturing Base and Competitors
Table 32. Sanofi-Aventis Major Business
Table 33. Sanofi-Aventis Bisphosphonate Drug Product and Services
Table 34. Sanofi-Aventis Bisphosphonate Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Global Bisphosphonate Drug Sales by Manufacturer (2019-2021e) & (K Units)
Table 36. Global Bisphosphonate Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 37. Market Position of Manufacturers in Bisphosphonate Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 38. Global Bisphosphonate Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 39. Head Office and Bisphosphonate Drug Production Site of Key Manufacturer
Table 40. Bisphosphonate Drug New Entrant and Capacity Expansion Plans
Table 41. Bisphosphonate Drug Mergers & Acquisitions in the Past Five Years
Table 42. Global Bisphosphonate Drug Sales by Region (2016-2021e) & (K Units)
Table 43. Global Bisphosphonate Drug Sales by Region (2021-2026) & (K Units)
Table 44. Global Bisphosphonate Drug Revenue by Region (2016-2021e) & (USD Million)
Table 45. Global Bisphosphonate Drug Revenue by Region (2021-2026) & (USD Million)
Table 46. Global Bisphosphonate Drug Sales by Type (2016-2021e) & (K Units)
Table 47. Global Bisphosphonate Drug Sales by Type (2021-2026) & (K Units)
Table 48. Global Bisphosphonate Drug Revenue by Type (2016-2021e) & (USD Million)
Table 49. Global Bisphosphonate Drug Revenue by Type (2021-2026) & (USD Million)
Table 50. Global Bisphosphonate Drug Price by Type (2016-2021e) & (USD/Unit)
Table 51. Global Bisphosphonate Drug Price by Type (2021-2026) & (USD/Unit)
Table 52. Global Bisphosphonate Drug Sales by Application (2016-2021e) & (K Units)
Table 53. Global Bisphosphonate Drug Sales by Application (2021-2026) & (K Units)
Table 54. Global Bisphosphonate Drug Revenue by Application (2016-2021e) & (USD Million)
Table 55. Global Bisphosphonate Drug Revenue by Application (2021-2026) & (USD Million)
Table 56. Global Bisphosphonate Drug Price by Application (2016-2021e) & (USD/Unit)
Table 57. Global Bisphosphonate Drug Price by Application (2021-2026) & (USD/Unit)
Table 58. North America Bisphosphonate Drug Sales by Country (2016-2021e) & (K Units)
Table 59. North America Bisphosphonate Drug Sales by Country (2021-2026) & (K Units)
Table 60. North America Bisphosphonate Drug Revenue by Country (2016-2021e) & (USD Million)
Table 61. North America Bisphosphonate Drug Revenue by Country (2021-2026) & (USD Million)
Table 62. North America Bisphosphonate Drug Sales by Type (2016-2021e) & (K Units)
Table 63. North America Bisphosphonate Drug Sales by Type (2021-2026) & (K Units)
Table 64. North America Bisphosphonate Drug Sales by Application (2016-2021e) & (K Units)
Table 65. North America Bisphosphonate Drug Sales by Application (2021-2026) & (K Units)
Table 66. Europe Bisphosphonate Drug Sales by Country (2016-2021e) & (K Units)
Table 67. Europe Bisphosphonate Drug Sales by Country (2021-2026) & (K Units)
Table 68. Europe Bisphosphonate Drug Revenue by Country (2016-2021e) & (USD Million)
Table 69. Europe Bisphosphonate Drug Revenue by Country (2021-2026) & (USD Million)
Table 70. Europe Bisphosphonate Drug Sales by Type (2016-2021e) & (K Units)
Table 71. Europe Bisphosphonate Drug Sales by Type (2021-2026) & (K Units)
Table 72. Europe Bisphosphonate Drug Sales by Application (2016-2021e) & (K Units)
Table 73. Europe Bisphosphonate Drug Sales by Application (2021-2026) & (K Units)
Table 74. Asia-Pacific Bisphosphonate Drug Sales by Region (2016-2021e) & (K Units)
Table 75. Asia-Pacific Bisphosphonate Drug Sales by Region (2021-2026) & (K Units)
Table 76. Asia-Pacific Bisphosphonate Drug Revenue by Region (2016-2021e) & (USD Million)
Table 77. Asia-Pacific Bisphosphonate Drug Revenue by Region (2021-2026) & (USD Million)
Table 78. Asia-Pacific Bisphosphonate Drug Sales by Type (2016-2021e) & (K Units)
Table 79. Asia-Pacific Bisphosphonate Drug Sales by Type (2021-2026) & (K Units)
Table 80. Asia-Pacific Bisphosphonate Drug Sales by Application (2016-2021e) & (K Units)
Table 81. Asia-Pacific Bisphosphonate Drug Sales by Application (2021-2026) & (K Units)
Table 82. South America Bisphosphonate Drug Sales by Country (2016-2021e) & (K Units)
Table 83. South America Bisphosphonate Drug Sales by Country (2021-2026) & (K Units)
Table 84. South America Bisphosphonate Drug Revenue by Country (2016-2021e) & (USD Million)
Table 85. South America Bisphosphonate Drug Revenue by Country (2021-2026) & (USD Million)
Table 86. South America Bisphosphonate Drug Sales by Type (2016-2021e) & (K Units)
Table 87. South America Bisphosphonate Drug Sales by Type (2021-2026) & (K Units)
Table 88. South America Bisphosphonate Drug Sales by Application (2016-2021e) & (K Units)
Table 89. South America Bisphosphonate Drug Sales by Application (2021-2026) & (K Units)
Table 90. Middle East & Africa Bisphosphonate Drug Sales by Country (2016-2021e) & (K Units)
Table 91. Middle East & Africa Bisphosphonate Drug Sales by Country (2021-2026) & (K Units)
Table 92. Middle East & Africa Bisphosphonate Drug Revenue by Country (2016-2021e) & (USD Million)
Table 93. Middle East & Africa Bisphosphonate Drug Revenue by Country (2021-2026) & (USD Million)
Table 94. Middle East & Africa Bisphosphonate Drug Sales by Type (2016-2021e) & (K Units)
Table 95. Middle East & Africa Bisphosphonate Drug Sales by Type (2021-2026) & (K Units)
Table 96. Middle East & Africa Bisphosphonate Drug Sales by Application (2016-2021e) & (K Units)
Table 97. Middle East & Africa Bisphosphonate Drug Sales by Application (2021-2026) & (K Units)
Table 98. Direct Channel Pros & Cons
Table 99. Indirect Channel Pros & Cons
Table 100. Bisphosphonate Drug Typical Distributors
Table 101. Bisphosphonate Drug Typical Customers
List of Figures
Figure 1. Bisphosphonate Drug Picture
Figure 2. Global Bisphosphonate Drug Sales Market Share by Type in 2020
Figure 3. Alendronate
Figure 4. Risedronate
Figure 5. Zoledronic Acid
Figure 6. Other Bisphosphonate Drug
Figure 7. Global Bisphosphonate Drug Sales Market Share by Application in 2020
Figure 8. Postmenopausal Osteoporosis
Figure 9. Men with Osteoporosis
Figure 10. Paget’s Disease
Figure 11. Bone Loss Caused by Cancer Treatment
Figure 12. Osteoporosis Imperfecta in Children
Figure 13. Global Bisphosphonate Drug Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 14. Global Bisphosphonate Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 15. Global Bisphosphonate Drug Sales (2016-2026) & (K Units)
Figure 16. Global Bisphosphonate Drug Price by Type (2016-2026) & (USD/Unit)
Figure 17. Global Bisphosphonate Drug Production Capacity (2016-2026) & (K Units)
Figure 18. Global Bisphosphonate Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 19. Bisphosphonate Drug Market Drivers
Figure 20. Bisphosphonate Drug Market Restraints
Figure 21. Bisphosphonate Drug Market Trends
Figure 22. Global Bisphosphonate Drug Sales Market Share by Manufacturer in 2020
Figure 23. Global Bisphosphonate Drug Revenue Market Share by Manufacturer in 2020
Figure 24. Bisphosphonate Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 25. Top 3 Bisphosphonate Drug Manufacturer (Revenue) Market Share in 2020
Figure 26. Top 6 Bisphosphonate Drug Manufacturer (Revenue) Market Share in 2020
Figure 27. Global Bisphosphonate Drug Sales Market Share by Region (2016-2026)
Figure 28. Global Bisphosphonate Drug Revenue Market Share by Region (2016-2026)
Figure 29. North America Bisphosphonate Drug Revenue (2016-2026) & (USD Million)
Figure 30. Europe Bisphosphonate Drug Revenue (2016-2026) & (USD Million)
Figure 31. Asia-Pacific Bisphosphonate Drug Revenue (2016-2026) & (USD Million)
Figure 32. South America Bisphosphonate Drug Revenue (2016-2026) & (USD Million)
Figure 33. Middle East & Africa Bisphosphonate Drug Revenue (2016-2026) & (USD Million)
Figure 34. Global Bisphosphonate Drug Sales Market Share by Type (2016-2026)
Figure 35. Global Bisphosphonate Drug Revenue Market Share by Type (2016-2026)
Figure 36. Global Bisphosphonate Drug Price by Type (2016-2026) & (USD/Unit)
Figure 37. Global Bisphosphonate Drug Sales Market Share by Application (2016-2026)
Figure 38. Global Bisphosphonate Drug Revenue Market Share by Application (2016-2026)
Figure 39. Global Bisphosphonate Drug Price by Application (2016-2026) & (USD/Unit)
Figure 40. North America Bisphosphonate Drug Sales Market Share by Type (2016-2026)
Figure 41. North America Bisphosphonate Drug Sales Market Share by Application (2016-2026)
Figure 42. North America Bisphosphonate Drug Sales Market Share by Country (2016-2026)
Figure 43. North America Bisphosphonate Drug Revenue Market Share by Country (2016-2026)
Figure 44. United States Bisphosphonate Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Bisphosphonate Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Bisphosphonate Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Bisphosphonate Drug Sales Market Share by Type (2016-2026)
Figure 48. Europe Bisphosphonate Drug Sales Market Share by Application (2016-2026)
Figure 49. Europe Bisphosphonate Drug Sales Market Share by Country (2016-2026)
Figure 50. Europe Bisphosphonate Drug Revenue Market Share by Country (2016-2026)
Figure 51. Germany Bisphosphonate Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Bisphosphonate Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Bisphosphonate Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Bisphosphonate Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Bisphosphonate Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Bisphosphonate Drug Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Bisphosphonate Drug Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Bisphosphonate Drug Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific Bisphosphonate Drug Revenue Market Share by Region (2016-2026)
Figure 60. China Bisphosphonate Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Bisphosphonate Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Korea Bisphosphonate Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Bisphosphonate Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Bisphosphonate Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Bisphosphonate Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Bisphosphonate Drug Sales Market Share by Type (2016-2026)
Figure 67. South America Bisphosphonate Drug Sales Market Share by Application (2016-2026)
Figure 68. South America Bisphosphonate Drug Sales Market Share by Country (2016-2026)
Figure 69. South America Bisphosphonate Drug Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Bisphosphonate Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Bisphosphonate Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East & Africa Bisphosphonate Drug Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Bisphosphonate Drug Sales Market Share by Application (2016-2026)
Figure 74. Middle East & Africa Bisphosphonate Drug Sales Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Bisphosphonate Drug Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Bisphosphonate Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Egypt Bisphosphonate Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Bisphosphonate Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. South Africa Bisphosphonate Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
世界の末梢動脈疾患用薬剤溶出性バルーン市場 2021：企業別、地域別、種類・用途別 The Drug Eluting Balloon for Peripheral Artery Disease market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain …- パーキンソン病の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Researchers are working to develop new and improved therapies for people with Parkinson's disease (PD). There have been many drugs that have been approved to treat Parkinson disease. Scope of the Report: This report focuses on the Parkinsons disease Drug in global market, especially in North America…
- シミジア（セルトリズマブ）医薬品の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Certolizumab pegol is a TNF (tumor necrosis factor) inhibitor that is primarily used to treat Crohns disease. Certolizumab pegol is a monoclonal antibody directed against tumor necrosis factor alpha (TNF-alfa). In 2008, it was approved for rheumatoid arthritis treatment under the brand CIMZIA®. It …
- ナタリズマブ薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to severe Crohn's disease in adults. Tysabri is usually given after other Crohn's disease medications have been tried without successful treatment of this con…
- 世界のドルテグラビル/リルピビリン併用薬市場 2021：企業別、地域別、種類・用途別 The Dolutegravir/Rilpivirine Combination Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…